4
Changes in Ownership
Inmune Bio, Inc. Filed Acc 0001213900-24-106916
Options or other derivatives
- Chief Scientific Officer acquired 140,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lowdell Mark William Chief Scientific Officer | 2024-12-05 | Grant or award · Option (right to buy) | +140,000 | 140,000 | D | ||
Loading xslF345X05/ownership.xml…